HeyRenee Raises $4.4M for Care Concierge Platform

c

What You Should Know:

HeyRenee, the newest health-tech innovation from Dr. Renee Dua and Nick Desai, the founders of Heal, today announced an oversubscribed $4.4M Seed II funding round led by Quiet Capital, with participation from City Light Capital, Fika Ventures, Global Founders Capital, Mucker Capital, SaaS Ventures, and Tau Ventures. HeyRenee has raised a total of $8.2 million and tripled its valuation in just five months.

– Set to launch in early spring 2022, HeyRenee aims to be the first-ever open platform to work with every provider, partner, and point solution to seamlessly curate the perfect combination of services for each patient’s specific needs and then guide patients through an easy, interactive daily plan.  

Why It Matters

Though coordinated care has been reportedly proven to lower healthcare costs by $7,700 per patient per year, a staggering 74 percent of seniors still lack a coordinated care plan. This problem is exacerbated by the reality that 53 million Americans already struggle to care for older loved ones and there will be a shortage of 1.2 million home health aides in the next decade. An aging population with over 100 million Americans suffering from two or more chronic diseases is driving the fast growing $9.6 billion per year U.S. market for care management software solutions. HeyRenee aims to ease this burden through high touch, coordinated care across the entire healthcare ecosystem, starting with patients and doctors.

“HeyRenee is a personal healthcare assistant that unifies the myriad complex aspects of healthcare into one intuitive, delightful experience specifically designed for underprivileged, older Americans who often have lower health and tech literacy and multiple health, social, and cultural factors that require coordinated attention to realize improved outcomes,” said Nick Desai, Co-Founder and CEO of HeyRenee. “Quiet Capital and Morgan Livermore are exceptionally high value-added lead investors. Along with Fika, Tau, and our other investors, they fuel our unrelenting pursuit of health equity for all Americans.”